Skip to main content
GALT logo

GALT · Galectin Therapeutics Inc

$3.85 -0.16 (-3.88%) At close · Jul 21
Market Cap
$253.22M
Shares
65.86M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2024
Executive Total
Joel Lewis $1,189,674
Khurram Jamil $945,847
Jack W. Callicutt $716,945
Fiscal 2023
Executive Total
Joel Lewis $963,647
Pol F. Boudes $770,280
Jack W. Callicutt $561,419
Fiscal 2022
Executive Total
Joel Lewis $974,181
Pol F. Boudes $794,577
Jack W. Callicutt $566,564
Fiscal 2021
Executive Total
Joel Lewis $1,167,621
Pol F. Boudes $923,683
Jack W. Callicutt $705,918
Fiscal 2020
Executive Total
Pol F. Boudes $1,082,481
Harold H. Shlevin $919,336
Joel Lewis $753,558
Jack W. Callicutt $720,372
Fiscal 2019
Executive Total
Harold H. Shlevin $1,306,507
Jack W. Callicutt $778,124
Fiscal 2018
Executive Total
Harold H. Shlevin $1,730,815
Jack W. Callicutt $1,266,497
Fiscal 2017
Executive Total
Jack W. Callicutt $406,011
Harold H. Shlevin $405,155
Key facts CIK 1133416 CUSIP 363225202 13F (30d) 7 filings 7 filers Visit website Investor relations